Mordecai Kramer is a life sciences professional with over 20 years of experience in therapeutics, medical devices and diagnostics research and development. For the past 16 years he has developed and managed new business activities, orchestrating nearly $500MM in complex clinical trial engagements at Baim Institute for Clinical Research, a boutique Academic CRO (Contract Research Organization). He is widely recognized for engaging with and bringing together cross functional trial operations teams, pharmaceutical, medical device, and biotech sponsors, academia, regulatory agencies and corporate partners to design and deploy global clinical trials that have benefited patients worldwide. Prior to that, he helped develop and commercialize several therapeutic and diagnostic products for Odyssey Therapeutics and the Cambridge Biomedical Research Group. Mordecai has undergraduate degrees in Accounting and Economics from Yeshiva University and an MBA in International Business from McGill University.